The Efficacy of the EORTC Risk Table for the Prediction of Recurrence and Progression of Non-Muscle-invasive Bladder Cancer:Report of 248 Cases

Xinru ZHANG,Yong QIAO,Baojun GU,Chao FENG,Hong XIE,Zhangshun LIU,Ying LIU

DOI: https://doi.org/10.3969/j.issn.1001-1420.2011.12.016

2011-01-01

Journal of Clinical Urology

Abstract:Objective:To value the efficacy of the EROTC Risk Scoring System and Risk Tables for the prediction of recurrence and progression of non-muscle-invasive bladder cancer.Methods:248 patients who were diagnosed as T_0 or T_1 bladder cancer from 2006.7 to 2010.3 were analyzed.The basic tumor dala,including the tumor quantity,size,grade,T category,prior recurrence history and accompanied with CIS or not were recorded. We scored these patients followed the EROTC Risk Scoring System and Risk Tables,and surveyed their recurrence and progression rate after transurethral tumor resection.Results:The score of tumor recurrence was 0-15, mean(4.37±2.93),and the score of tumor regression was 0-23,mean(5.21±3.95).During 3-60 months (mean 25.8±18.5 months) follow-up period,123(49.6%)lumor recurrences were detected(mean 11.4±6.5 months),and the tumors in 87 cases(70.7%)recurred within 12 months post operative.24(19.5%)tumor progression were detected(mean 9.8±6.2 months).The recurrence rale was less than 20%in the patients with 0-2 recurrence score,and no progression case was delected in the patients with progression score less than 2.6.1% progression rate was for the patients scored 3 in progression score.The tumor quantity was the first risk factor for both of tumor recurrence and progression,the hazard rale was 2.229 and 5.246 respectively.Conclusions:The EORTC scoring table is effective for the prognosis of non-muscle-invasive bladder cancer.It is still necessary to modify for adapting the needs of Chinese patients cohorts.